Scholarly Index
Charles G. Mullighan
St. Jude Children's Research Hospital; 62,501 total citations; 720 total publications; best world rank #7
St. Jude Children's Research Hospital
62,501Total citations
720Total publications
118H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Acute Lymphoblastic Leukemia research | Lifetime | 7 | US 7 | 99.93 |
| Childhood Cancer Survivors' Quality of Life | Lifetime | 12 | US 9 | 99.83 |
| Acute Myeloid Leukemia Research | Lifetime | 26 | US 19 | 99.85 |
| Chronic Myeloid Leukemia Treatments | Lifetime | 21 | US 17 | 99.82 |
| Cancer Genomics and Diagnostics | Lifetime | 320 | US 192 | 99.38 |
| Epigenetics and DNA Methylation | Lifetime | 733 | US 387 | 98.32 |
| Chronic Lymphocytic Leukemia Research | Lifetime | 576 | US 266 | 98.51 |
| Genomic variations and chromosomal abnormalities | Lifetime | 692 | US 290 | 95.96 |
| Complement system in diseases | Lifetime | 769 | US 294 | 94.23 |
| Acute Lymphoblastic Leukemia research | 2021-2025 | 10 | US 8 | 99.86 |
| Acute Myeloid Leukemia Research | 2021-2025 | 49 | US 36 | 99.47 |
| Childhood Cancer Survivors' Quality of Life | 2021-2025 | 43 | US 29 | 98.70 |
| Cancer Genomics and Diagnostics | 2021-2025 | 365 | US 169 | 97.49 |
| Chronic Myeloid Leukemia Treatments | 2021-2025 | 143 | US 75 | 97.32 |
| Protein Degradation and Inhibitors | 2021-2025 | 888 | US 372 | 85.36 |